#

IPO

: 404
Shares in chipmaker Cerebras soared 80% after the start of trading / Photo: X / Cerebras
News·
Shares of rival Nvidia soared nearly 90% after the biggest IPO of the year
Cerebras IPO was the largest listing in 2026 / Photo: Cerebras
News·
Cerebras IPO: shares of Nvidia's AI chip rival become available
A company that makes money by leasing oil and gas lands it controls for use has gone public / Photo: unsplash.com / Brad Weaver
News·
EagleRock Land IPO: Oil royalty landowner goes public
The convergence of AI, cloud computing, and broader economic digitalization is driving unprecedented demand for data centers globally, the company argued in its prospectus / Photo: Unsplash / Geoffrey Moffett
Small Caps·
+1
·
Blackstone Digital Infrastructure IPO: Data center REIT debuts on NYSE
Microsoft intends to develop its own neural network to be less dependent on OpenAI / Photo: Copyright Lawrey/Shutterstock.com
News·
Life after OpenAI: Microsoft has started hunting for new AI startups, Reuters has found out
Uzbekistan Fund rises at debut auction in London / Photo: Bakhodir Saidov / Shutterstock
News·
Uzbekistan investment fund rose in price in London after IPO by $604 mln
Fervo uses horizontal drilling and multi-stage hydraulic fracturing to produce geothermal energy and expects to deliver power at its first commercial station by the end of 2026 / Photo: Fervo Energy
News·
+1
·
Fervo Energy IPO: Geothermal energy developer debuts on the Nasdaq
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Microsoft and OpenAI are once again changing the terms of their partnership / Photo: JRdes/Shutterstock.com
News·
Ceiling for Microsoft: OpenAI to save nearly $100 billion in partner payments for IPO
US rejects Irans response to settle 10-week war: Donald Trump called it totally unacceptable / Photo: Studio Romantic / Shutterstock
Review·
Top stories for the morning: US rejects Iran's peace terms, Cerebras raises IPO valuation
Founded in 2021, Odyssey is developing therapies to treat patients with autoimmune diseases like ulcerative colitis, Crohn’s disease, and lupus / Photo: Odyssey Therapeutics
Small Caps·
Odyssey IPO: Immune system biotech debuts on the Nasdaq
Mobia Medicals development - Vivistim device for vagus nerve stimulation / Photo: Vivistim.com
News·
Mobia Medical IPO: developer of stroke rehabilitation systems goes public
Load more